3,5-diaMino-N-carbaMothioyl-6-chloropyrazine-2-carboxaMide manufacturers
|
| | 3,5-diaMino-N-carbaMothioyl-6-chloropyrazine-2-carboxaMide Basic information |
| Product Name: | 3,5-diaMino-N-carbaMothioyl-6-chloropyrazine-2-carboxaMide | | Synonyms: | 3,5-diaMino-N-carbaMothioyl-6-chloropyrazine-2-carboxaMide;3,5-Diamino-N-(aminothioxomethyl)-6-chloro-2-pyrazinecarboxamide;1-(3,5-Diamino-6-chloropyrazine-2-carbonyl)-thiourea;3,5-Diamino-N-(aminothioxomethyl)-6-chloropyrazinecarboxamide;2-Pyrazinecarboxamide, 3,5-diamino-N-(aminothioxomethyl)-6-chloro-;3,5-Diamino-N-carbamothioyl-6-chloro-2-pyrazinecarboxamide | | CAS: | 30478-39-8 | | MF: | C6H7ClN6OS | | MW: | 246.68 | | EINECS: | | | Product Categories: | | | Mol File: | 30478-39-8.mol |  |
| | 3,5-diaMino-N-carbaMothioyl-6-chloropyrazine-2-carboxaMide Chemical Properties |
| | 3,5-diaMino-N-carbaMothioyl-6-chloropyrazine-2-carboxaMide Usage And Synthesis |
| Uses | 3,5-Diamino-N-(aminothioxomethyl)-6-chloropyrazinecarboxamide, is a synthetic building block, and a starting material in the synthesis of the drug 552-02 (CAS#587879-54-7) which is an inhaled sodium-channel blocker currently in clinical trials. |
| | 3,5-diaMino-N-carbaMothioyl-6-chloropyrazine-2-carboxaMide Preparation Products And Raw materials |
|